FDANonrulemakingFDA-2013-D-1039
Who commented on this docket
Endocrine Disruption Potential of Drugs: Nonclinical Evaluation
1 organizations filed 1 public comment on Endocrine Disruption Potential of Drugs: Nonclinical Evaluation, at the Food and Drug Administration. The comment window closed 4634d ago.
Organizations
1
Comments
1
RIN
—
Comment window
closed 4634d ago
Commenters (1)
- American Chemistry Counciltrade assoc.1 filing · confidence 97%
Attribution is name-based and imperfect. regulations.gov data is public record.